183 related articles for article (PubMed ID: 8023744)
1. A synthetic peptide which specifically inhibits heat-treated interleukin-8 binding and chemotaxis for neutrophils.
Miller EJ; Kurdowska A; Nagao S; Carr FK; Hayashi S; Atkinson MA; Cohen AB
Agents Actions; 1993 Nov; 40(3-4):200-8. PubMed ID: 8023744
[TBL] [Abstract][Full Text] [Related]
2. Effect of human C-reactive protein on chemokine and chemotactic factor-induced neutrophil chemotaxis and signaling.
Zhong W; Zen Q; Tebo J; Schlottmann K; Coggeshall M; Mortensen RF
J Immunol; 1998 Sep; 161(5):2533-40. PubMed ID: 9725253
[TBL] [Abstract][Full Text] [Related]
3. Interaction of fibronectin (FN) cell binding fragments and interleukin-8 (IL-8) in regulating neutrophil chemotaxis.
Gudewicz PW; Heinel LA; Stanton K; Singleton D; Frewin MB
Biochem Biophys Res Commun; 1994 Nov; 205(1):706-13. PubMed ID: 7999101
[TBL] [Abstract][Full Text] [Related]
4. IL-8 induces neutrophil chemotaxis predominantly via type I IL-8 receptors.
Hammond ME; Lapointe GR; Feucht PH; Hilt S; Gallegos CA; Gordon CA; Giedlin MA; Mullenbach G; Tekamp-Olson P
J Immunol; 1995 Aug; 155(3):1428-33. PubMed ID: 7636208
[TBL] [Abstract][Full Text] [Related]
5. Contrasting responses to multiple chemotactic stimuli in transendothelial migration: heterologous desensitization in neutrophils and augmentation of migration in eosinophils.
Kitayama J; Carr MW; Roth SJ; Buccola J; Springer TA
J Immunol; 1997 Mar; 158(5):2340-9. PubMed ID: 9036983
[TBL] [Abstract][Full Text] [Related]
6. Human neutrophil Fc gamma RIIIB and formyl peptide receptors are functionally linked during formyl-methionyl-leucyl-phenylalanine-induced chemotaxis.
Kew RR; Grimaldi CM; Furie MB; Fleit HB
J Immunol; 1992 Aug; 149(3):989-97. PubMed ID: 1321856
[TBL] [Abstract][Full Text] [Related]
7. Chemical synthesis, purification, and characterization of two inflammatory proteins, neutrophil activating peptide 1 (interleukin-8) and neutrophil activating peptide.
Clark-Lewis I; Moser B; Walz A; Baggiolini M; Scott GJ; Aebersold R
Biochemistry; 1991 Mar; 30(12):3128-35. PubMed ID: 2007144
[TBL] [Abstract][Full Text] [Related]
8. Design and evaluation of small peptides mapping the exposed surface of IL-8.
Thompson SK; Veber DF; Jurewicz AJ; Peishoff CE; Lee JM; White JR
Int J Pept Protein Res; 1996 Mar; 47(3):214-8. PubMed ID: 8740972
[TBL] [Abstract][Full Text] [Related]
9. Peptides derived from C-reactive protein inhibit neutrophil alveolitis.
Heuertz RM; Ahmed N; Webster RO
J Immunol; 1996 May; 156(9):3412-7. PubMed ID: 8617967
[TBL] [Abstract][Full Text] [Related]
10. Synthetic hexa- and heptapeptides that inhibit IL-8 from binding to and activating human blood neutrophils.
Hayashi S; Kurdowska A; Miller EJ; Albright ME; Girten BE; Cohen AB
J Immunol; 1995 Jan; 154(2):814-24. PubMed ID: 7814885
[TBL] [Abstract][Full Text] [Related]
11. Chemoattractants induce rapid release of the interleukin 1 type II decoy receptor in human polymorphonuclear cells.
Colotta F; Orlando S; Fadlon EJ; Sozzani S; Matteucci C; Mantovani A
J Exp Med; 1995 Jun; 181(6):2181-6. PubMed ID: 7760005
[TBL] [Abstract][Full Text] [Related]
12. CD11b/CD18 mediates the neutrophil chemotactic activity of fibrin degradation product D domain.
Gross TJ; Leavell KJ; Peterson MW
Thromb Haemost; 1997 May; 77(5):894-900. PubMed ID: 9184399
[TBL] [Abstract][Full Text] [Related]
13. CXCL8((3-73))K11R/G31P antagonizes ligand binding to the neutrophil CXCR1 and CXCR2 receptors and cellular responses to CXCL8/IL-8.
Li F; Zhang X; Gordon JR
Biochem Biophys Res Commun; 2002 May; 293(3):939-44. PubMed ID: 12051749
[TBL] [Abstract][Full Text] [Related]
14. Recombinant human interleukin-8 is a potent activator of canine neutrophil aggregation, migration, and leukotriene B4 biosynthesis.
Thomsen MK; Larsen CG; Thomsen HK; Kirstein D; Skak-Nielsen T; Ahnfelt-Rønne I; Thestrup-Pedersen K
J Invest Dermatol; 1991 Feb; 96(2):260-6. PubMed ID: 1846901
[TBL] [Abstract][Full Text] [Related]
15. Purification and partial biochemical characterization of a human monocyte-derived, neutrophil-activating peptide that lacks interleukin 1 activity.
Schröder JM; Mrowietz U; Morita E; Christophers E
J Immunol; 1987 Nov; 139(10):3474-83. PubMed ID: 2824608
[TBL] [Abstract][Full Text] [Related]
16. A novel bioactive 31-amino acid endothelin-1 is a potent chemotactic peptide for human neutrophils and monocytes.
Cui P; Tani K; Kitamura H; Okumura Y; Yano M; Inui D; Tamaki T; Sone S; Kido H
J Leukoc Biol; 2001 Aug; 70(2):306-12. PubMed ID: 11493624
[TBL] [Abstract][Full Text] [Related]
17. A comparative study of the neutrophil stimulatory activity in vitro and pro-inflammatory properties in vivo of 72 amino acid and 77 amino acid IL-8.
Nourshargh S; Perkins JA; Showell HJ; Matsushima K; Williams TJ; Collins PD
J Immunol; 1992 Jan; 148(1):106-11. PubMed ID: 1727857
[TBL] [Abstract][Full Text] [Related]
18. Normal human epidermal keratinocyte-derived neutrophil chemotactic factor.
Takematsu H; Isono N; Kato T; Tagami H
Tohoku J Exp Med; 1990 Sep; 162(1):1-13. PubMed ID: 2077675
[TBL] [Abstract][Full Text] [Related]
19. Alteration of cellular cytosolic calcium and chemotactic peptide binding by an inhibitor of neutrophil function.
Cooper JA; Bridges TA; Kennedy JI; Culbreth R
Am J Physiol; 1994 Jul; 267(1 Pt 1):L71-8. PubMed ID: 8048544
[TBL] [Abstract][Full Text] [Related]
20. HIV-1 envelope gp41 peptides promote migration of human Fc epsilon RI+ cells and inhibit IL-13 synthesis through interaction with formyl peptide receptors.
de Paulis A; Florio G; Prevete N; Triggiani M; Fiorentino I; Genovese A; Marone G
J Immunol; 2002 Oct; 169(8):4559-67. PubMed ID: 12370393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
